Citations 3
A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas.
Agulnik, Mark , Rademaker, Alfred , Humphreys, Catherine, Abbinanti, Susan, Cehic, Rasima, Polish, Ariel, Vintilescu, Claudia Roxana, McFarland, Thomas, Okuno, Scott H. , Tine, Brian Andrew Van, Milhem, Mohammed , Humphreys, Catherine, Nye, Lauren Elizabeth , McFarland, Thomas, Skubitz, Keith M. , Robinson, Steven I.
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 10515-10515
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
Polish, Ariel, Abbinanti, Susan, Vintilescu, Claudia Roxana, Rademaker, Alfred , Humphreys, Catherine, Cehic, Rasima, McFarland, Thomas, Tine, Brian Andrew Van, Okuno, Scott H. , Agulnik, Mark , Nye, Lauren Elizabeth , Humphreys, Catherine, Milhem, Mohammed , Skubitz, Keith M.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS10604-TPS10604
A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
Agulnik, Mark , Mohindra, Nisha , Attia, Steven , Rademaker, Alfred , Abbinanti, Susan, Cehic, Rasima, Humphreys, Catherine , Okuno, Scott H. , Tine, Brian Andrew Van, Milhem, Mohammed , Robinson, Steven I. , Humphreys, Catherine, Prudner, Bethany Cheree
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11550-11550